NDC 61919-875

MAPAP

Mapap

MAPAP is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Directrx. The primary component is Acetaminophen.

Product ID61919-875_87d6ce0b-19db-84e0-e053-2a95a90a0090
NDC61919-875
Product TypeHuman Otc Drug
Proprietary NameMAPAP
Generic NameMapap
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-05-01
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart343
Labeler NameDirectRX
Substance NameACETAMINOPHEN
Active Ingredient Strength325 mg/1
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 61919-875-71

100 TABLET in 1 BOTTLE (61919-875-71)
Marketing Start Date2019-05-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 61919-875-71 [61919087571]

MAPAP TABLET
Marketing CategoryOTC monograph not final
Application Numberpart343
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-05-01

Drug Details

Active Ingredients

IngredientStrength
ACETAMINOPHEN325 mg/1

NDC Crossover Matching brand name "MAPAP" or generic name "Mapap"

NDCBrand NameGeneric Name
0904-1982MapapACETAMINOPHEN
0904-1987MAPAPAcetaminophen
0904-5751MapapAcetaminophen
0904-5816MapapAcetaminophen
0904-6536MapapAcetaminophen
33261-142MapapACETAMINOPHEN
49999-131MapapACETAMINOPHEN
50090-0266MapapACETAMINOPHEN
50090-2907MapapACETAMINOPHEN
50436-3220MapapACETAMINOPHEN
53808-0822MAPAPAcetaminophen
55154-1325MapapAcetaminophen
60760-935MapapACETAMINOPHEN
61919-857MAPAPMAPAP
61919-875MAPAPMAPAP
63629-6344MapapACETAMINOPHEN
70518-0470MapapACETAMINOPHEN
70518-1292MapapACETAMINOPHEN

Trademark Results [MAPAP]

Mark Image

Registration | Serial
Company
Trademark
Application Date
MAPAP
MAPAP
76126557 2490633 Live/Registered
Harvard Drug Group, LLC, The
2000-09-12
MAPAP
MAPAP
74215554 1732421 Dead/Cancelled
MAJOR PHARMACEUTICAL CORPORATION
1991-10-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.